Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0000899243-20-033903

10% owner sold 64,624 shares at an average $80.14 ($5,179,285)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
BRATTON DOUGLAS K 10% owner 2020-12-11 Sale −46,799 $80.05 $3,746,442 401,236 I: show line 1 in the form
BRATTON DOUGLAS K 10% owner 2020-12-14 Sale −16,949 $80.35 $1,361,774 384,287 I: show line 2 in the form
BRATTON DOUGLAS K 10% owner 2020-12-14 Sale −876 $81.13 $71,068 383,411 I: show line 3 in the form
Open-market sales · 64,624 sh · avg $80.14 · $5,179,285
Loading xslF345X03/doc4.xml…